BG Medical Technologies to Give Free Medical Marijuana Educational Materials to Physicians

As a result of ongoing legalization throughout the United States for medical marijuana, BG Medical Technologies (OTC:RIGH) and its forthcoming subsidiary Genius Biotech Corporation are developing training materials for physicians interested in learning more about recommending medical marijuana as part of health treatment programs. The planned materials are to include strain-specific medicinal qualities as well as cannabinoid interactions. The available materials will include access to free online resources designed to help physicians best match remedies to their patients’ ailments.

A leader in online medical marijuana information, BG Medical plans to expand its online tools into materials for future medical marijuana doctors and caregivers. The materials will be made available both by website and distributable e-reader PDF formats.

CEO Angel Stanz explains, “The wide array of cannabis strains available in the marketplace today creates confusion. This chaos is compounded in emerging markets due to a lack of local expertise. BG Medical believes that a quantitative data and laboratory-based approach is needed to resolve these early market struggles. BudGenius.com has been collecting strain information and patient feedback from as early as 2010. Our aim is to become the Physician’s Desk Reference (PDR) for strain-specific, grower-specific, and even harvest-specific treatments. In an emerging cannabis market, this is a doctor’s best friend.”

BG Medical expects other reputable companies within matured medical marijuana regions to join in the development of these free resources to help ensure that the training is helpful and comprehensive.

Mr. Stanz continued, “In addition to this being a valuable resource for recommending physicians, this is also an organic marketing format for brands and personnel with an authentic interest in medical efficacy to expand themselves into new markets with a professional caring-forward position.”

To pre-register for the educational program materials, physicians and staff should email their name, title, type of practice or specialty, clinic and/or treatment facility name, and state where licensed to: [e-mail].

About BG Medical Technologies

BG Medical Technologies is a medical marijuana company that develops technology and research software for cannabis and natural health solutions. The Company collects data through a network of proprietary software, utilized by patients, by retail operators, and by medical professionals. The Company's current flagship product, BudGenius.com, is a social web platform connecting cannabis patients to regionally available medicine that is paired to their needs. The Company operates an analytical chemistry laboratory designed for cannabis study, utilized to determine potency and safety guidance for patients and medicine manufacturers.

For more information please visit:http://www.BudGenius.comhttp://www.BgMedTech.com

The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.

BG Medical Technologies, Inc.Angel Stanz, 855-723-3283Chief Executive [e-mail]